NAIL-MS显示tRNA和rRNA的低修饰是5-甲治疗的结果
Maximilian Berg1, Chengkang Li1, Stefanie Kaiser1
1Department of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt 60438, Germany.
Nucleic acids research
|February 25, 2025
概括
抗癌药物5-甲 (5-FU) 在转移RNA (tRNA) 和核糖体RNA (rRNA) 中引起广泛的RNA低基因改性. 这种RNA修饰缺陷是5-FU的潜在新机制.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 癌症研究 癌症研究
背景情况:
- 传统上已知抗癌药物5-fluorouracil (5-FU) 可以抑制甲基酸合成酶.
- 新出现的证据表明,5-FU毒性可能涉及核糖体碰撞和核糖体RNA (rRNA) 处理中的缺陷.
- 5-FU对RNA修饰的影响,特别是在转移RNA (tRNA) 和rRNA中,需要进一步研究.
研究的目的:
- 为了研究5-FU暴露对人体细胞中tRNA和rRNA修饰的影响.
- 阐明RNA低修饰在5-FU的作用机制中的作用.
主要方法:
- 用5-FU对待HEK293T细胞.
- 在tRNA和rRNA中的关键RNA修饰的量化.
- 核酸同位素标记与质谱学 (NAIL-MS) 结合使用,以区分先前存在的RNA与新合成的RNA的修改.
主要成果:
- 在tRNA中观察到5-甲基尤里丁和伪尤里丁 (Ψ) 修饰的显著减少 (55%和40%).
- 新合成的tRNA和rRNA显示了各种修饰的大量损失,包括 Ψ和核糖酶甲基化,而先前存在的RNA仍然被修饰.
- 在新转录的成熟rRNA中检测到成熟rRNA和低修饰水平的降低.
结论:
- 5-FU在tRNA和rRNA中都会诱导显著的RNA低调.
- 新合成的RNA特别容易受到5FU处理后的修饰缺陷的影响.
- RNA低基因改造代表了一种潜在的分子机制,有助于5-FU的抗癌活性.
相关概念视频
Translation
133.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
133.8K
Nuclear Export of mRNA
7.1K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.1K
Translation
16.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
16.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84


